Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5073308018 | Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5073309014 | Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5073310016 | Amlodipine (as amlodipine besylate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Is a | Product containing only amlodipine and metoprolol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Conventional release and prolonged-release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Amlodipine besilate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Amlodipine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Metoprolol succinate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Metoprolol tartrate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and metoprolol tartrate (as metoprolol succinate) 50 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR